MIR3682

Across TCGA pan-cancer cohorts, MIR3682 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MIR3682 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3682 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3682 expression acts as an unfavorable survival marker, although some lineages such as READ and PAAD show a favorable association.

KIRC, UVM, and ACC are the cancer types where MIR3682 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.531	0.713	<.001	182	view →
UVM	DFS	Median	III,IV	0.244	0.751	<.001	81	view →
ACC	DFS	Median	IV	0.066	0.495	.001	55	view →
READ	OS	Median	III,IV	0.650	0.280	<.001	49	view →
ESCA	OS	Median	All	0.570	0.781	.003	47	view →
PAAD	OS	Quartile	All	0.663	0.342	<.001	42	view →
KIRP	DFS	Tertile	III,IV	0.105	0.604	.001	31	view →
LGG	DFS	Median	All	0.615	0.342	.001	29	view →
SKCM	OS	Quartile	IV	1.000	0.282	.006	22	view →
BLCA	DFS	Median	IV	0.552	0.385	.014	16	view →
LUAD	DFS	Quartile	III,IV	0.407	0.752	.012	15	view →
UCS	OS	Tertile	IV	0.449	0.828	.036	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MIR3682–KIRC (DFS)

Open the KIRC breakdown →